Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
about
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 systemEpidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in ItalyEpidemiology of invasive candidiasis: a persistent public health problemHospital epidemiology and infection control in acute-care settings.A cluster of Candida krusei infections in a haematological unit.Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western ChinaThe effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.Risk factors for fluconazole-resistant Candida glabrata bloodstream infectionsNationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in SpainRecent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsEpidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centersAntibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionImpact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.Current options in antifungal pharmacotherapy.Treatment of invasive candidiasis in the elderly: a reviewA single-centre 10-year experience with Candida bloodstream infections.Blood stream infections by Candida glabrata and Candida krusei: a single-center experienceEpidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Invasive fungal infections in the ICU.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Antifungal susceptibility testing: a primer for clinicians.Fungal infections in burns: a comprehensive review.Concise review: next-generation cell therapies to prevent infections in neutropenic patients.Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?Risk factors for fluconazole-resistant candidemia.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Factors Influencing Non-albicans Candidemia: A Case-Case-Control Study.Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards.Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure?
P2860
Q28260910-F35205C1-D811-411E-8BB8-7FB50EE887AAQ28597069-01B9FAF9-A09E-400A-A4E9-B8C93A9FAE94Q28740362-612A145B-C579-4C25-A00B-57719D6E6C36Q29616758-BAA8DC0C-50C1-4D75-A087-A99A0C0EAB89Q30429049-98C42453-EC2C-4A2B-8EBD-3D0A0E3D2F8AQ33294780-3BDE0186-C534-49B3-96A6-102D2FC98F67Q33644932-181D2349-F00B-4533-AEDA-D4C1E5C1FA1EQ33887429-082A408C-4194-48CE-B276-349F4DA120DAQ33932340-47219E3D-75AF-4AA8-A5BE-0494FDB97776Q34489579-B16A5AF6-48A9-4B98-AB44-3F2AB1EFB3BAQ34529026-D2D1B99B-FC37-4EA2-BCFE-74FB1AB43C84Q35073043-F33CC991-5320-4771-AAF6-DBDDEDDD2947Q35941512-63E5B2A8-F8A0-4F60-B8A3-C26440341B8BQ36018860-A887FD34-0A58-48FA-94D7-3D256A0AF5F5Q36237993-78D175D2-1340-4ADA-8A6D-915F8600B813Q36825717-BC66EA49-A13D-4064-AF43-83D81509B169Q36898053-F168B8AF-9A34-44BC-BA5E-98A923904012Q37048679-67A38B75-2EA3-41C5-AD47-7FC7773E3F04Q37151326-87CF774C-9142-418A-BE84-C61179B22F2FQ37170218-65FDEC2A-DC0A-4458-A170-FFAC8A2777A1Q37252122-2635123F-C697-494E-AB6D-BD9B3DD803E3Q37320979-C445F753-2A67-4EE9-8BDD-539B81046004Q37336194-72DDF8EC-C487-49F3-841D-C57B9D8B5BEEQ37580801-F7FCF794-0AF1-416C-B1B0-79F402F3D193Q37643057-B00EE220-57FF-414F-B09E-8DAE2155723AQ37650317-9D4F6C2B-7695-4647-888C-75ECE83A86F1Q38061087-C0283F66-9636-472F-9538-8547A200D7BAQ38190539-2AB9D799-63CA-4EA5-B57E-3DF754212409Q38193653-324A1508-E4E8-40E1-9862-B192FEEAA1EBQ39553745-72D81665-BCF1-4D8B-85E1-872E7F87AB05Q39934814-B5D14AE2-49B0-4BE8-A20A-1B6EEA877EACQ40169961-9A29B1AE-B9BC-4EE2-BB94-B34D4FD0A0CDQ40205203-09DAD156-82DE-4404-AB1C-CDD066F0FFF8Q40757551-610243DD-429E-45C7-8BFE-603C977CB746Q42210762-FB75EA42-CA64-4F78-9EF1-68174F2FE969Q43108559-5F5EBAA1-02D7-450D-8097-250056CBDE7FQ43701370-154DA600-6189-4058-B463-710CC82DB000Q43737173-43CC273C-4B74-4392-A7B1-F026D62F0D34Q44693688-F4607113-D4B5-4083-8166-A246569862D9Q44919501-EC0A78ED-D9A0-4530-B6EE-A1475A9D0E37
P2860
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@ast
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@en
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@nl
type
label
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@ast
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@en
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@nl
prefLabel
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@ast
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@en
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@nl
P2093
P2860
P1476
Prior antimicrobial therapy an ...... ia: a case-case-control study.
@en
P2093
Ernesto L Flores
Jennifer Zumsteg
Jocelyn Tolentino
Michael Y Lin
Pranavi Sreeramoju
Stephen G Weber
Yehuda Carmeli
P2860
P304
P356
10.1128/AAC.49.11.4555-4560.2005
P407
P577
2005-11-01T00:00:00Z